Agency Releases Final Guidance for IPAY 2028 of the Medicare Drug Price Negotiation Program and Effectuation of Maximum Fair Price in 2026-2028; Implements H.R. 1 Orphan Drug Exclusion Expansion
September 30, 2025 | |
Agency Releases Final Guidance for IPAY 2028 of the Medicare Drug Price Negotiation Program and Effectuation of Maximum Fair Price in 2026-2028; Implements H.R. 1 Orphan Drug Exclusion Expansion
The Centers for Medicare and Medicaid Services released final guidance for initial price applicability year (IPAY) 2028 of the Medicare Drug Price Negotiation Program and effectuation of maximum fair prices (MFPs) in IPAYs 2026, 2027, and 2028 (press release, fact sheet). What is it. The draft guidance described how CMS will implement the Negotiation Program for IPAY 2028 and included… (Slifer, September 30, 2025) #Drug Pricing, #Medicare Part D, #Prescription Drugs